Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
COVID-19 vaccines have shown high efficacy, with most side effects being mild–moderate and more frequently reported by females and people at younger ages. Since no studies have assessed the impact that weight status could have on the reported adverse reactions, we aim to study the association betwee...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c0de24d36791409583c373aa57a3377a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c0de24d36791409583c373aa57a3377a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c0de24d36791409583c373aa57a3377a2021-11-25T19:11:18ZAssociation between COVID-19 Vaccine Side Effects and Body Mass Index in Spain10.3390/vaccines91113212076-393Xhttps://doaj.org/article/c0de24d36791409583c373aa57a3377a2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1321https://doaj.org/toc/2076-393XCOVID-19 vaccines have shown high efficacy, with most side effects being mild–moderate and more frequently reported by females and people at younger ages. Since no studies have assessed the impact that weight status could have on the reported adverse reactions, we aim to study the association between weight status and reported side effects. We included data on 2136 adults from an online survey conducted from 6 May to 9 June 2021. The questionnaire was filled in by participants over Google forms. Generalized Linear Mixed Models were used. A higher risk of presenting fever ≥38°, vomiting, diarrhea and chills was found in those with a non-overweight status compared to those overweight after adjusting for age, sex, education, medication to prevent/relieve post-vaccination effects and vaccine administered. When adjusting, most of the significant effects, in the association between side effects of the COVID-19 vaccine and weight status, did not remain significant. In conclusion, a non-overweight status was associated with a higher risk of presenting fever ≥38°, vomiting, diarrhea and chills compared to those overweight. Nevertheless, most of the reported side effects to COVID-19 vaccine were not associated with a higher risk of presenting more adverse effects, and individual differences were determined by sex and age.Isabel IguacelAurelio Luna MaldonadoAurelio Luna Ruiz-CabelloMarta CasausLuis Alberto MorenoBegoña Martínez-JarretaMDPI AGarticleSARS CoV-2vaccinationoverweightobesityvaccine adverse eventsMedicineRENVaccines, Vol 9, Iss 1321, p 1321 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
SARS CoV-2 vaccination overweight obesity vaccine adverse events Medicine R |
spellingShingle |
SARS CoV-2 vaccination overweight obesity vaccine adverse events Medicine R Isabel Iguacel Aurelio Luna Maldonado Aurelio Luna Ruiz-Cabello Marta Casaus Luis Alberto Moreno Begoña Martínez-Jarreta Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain |
description |
COVID-19 vaccines have shown high efficacy, with most side effects being mild–moderate and more frequently reported by females and people at younger ages. Since no studies have assessed the impact that weight status could have on the reported adverse reactions, we aim to study the association between weight status and reported side effects. We included data on 2136 adults from an online survey conducted from 6 May to 9 June 2021. The questionnaire was filled in by participants over Google forms. Generalized Linear Mixed Models were used. A higher risk of presenting fever ≥38°, vomiting, diarrhea and chills was found in those with a non-overweight status compared to those overweight after adjusting for age, sex, education, medication to prevent/relieve post-vaccination effects and vaccine administered. When adjusting, most of the significant effects, in the association between side effects of the COVID-19 vaccine and weight status, did not remain significant. In conclusion, a non-overweight status was associated with a higher risk of presenting fever ≥38°, vomiting, diarrhea and chills compared to those overweight. Nevertheless, most of the reported side effects to COVID-19 vaccine were not associated with a higher risk of presenting more adverse effects, and individual differences were determined by sex and age. |
format |
article |
author |
Isabel Iguacel Aurelio Luna Maldonado Aurelio Luna Ruiz-Cabello Marta Casaus Luis Alberto Moreno Begoña Martínez-Jarreta |
author_facet |
Isabel Iguacel Aurelio Luna Maldonado Aurelio Luna Ruiz-Cabello Marta Casaus Luis Alberto Moreno Begoña Martínez-Jarreta |
author_sort |
Isabel Iguacel |
title |
Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain |
title_short |
Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain |
title_full |
Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain |
title_fullStr |
Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain |
title_full_unstemmed |
Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain |
title_sort |
association between covid-19 vaccine side effects and body mass index in spain |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/c0de24d36791409583c373aa57a3377a |
work_keys_str_mv |
AT isabeliguacel associationbetweencovid19vaccinesideeffectsandbodymassindexinspain AT aureliolunamaldonado associationbetweencovid19vaccinesideeffectsandbodymassindexinspain AT aureliolunaruizcabello associationbetweencovid19vaccinesideeffectsandbodymassindexinspain AT martacasaus associationbetweencovid19vaccinesideeffectsandbodymassindexinspain AT luisalbertomoreno associationbetweencovid19vaccinesideeffectsandbodymassindexinspain AT begonamartinezjarreta associationbetweencovid19vaccinesideeffectsandbodymassindexinspain |
_version_ |
1718410239909298176 |